Home/ Supplements/ Colostrum/ Laktoferrin with Colostrum

Laktoferrin with Colostrum

product on market Capsule Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Laktoferrin with Colostrum
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
22
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1 Gram(s)
Market median: 800.0mg (172 products)
Lactoferrin
400 mg
Lysozyme
20 mg

Other Ingredients

Hydroxypropyl Methylcellulose L-Leucine
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use As a dietary supplement, 1 to 4 capsules at night before bed, or as directed by a healthcare practitioner.

Warnings & Precautions

Contains: Milk, egg.

Formulation Notes

Laktoferrin with Colostrum provides purified lactoferrin in a base of colostrum. Prepared with lysozyme.

Variations in product color may occur.

Enhanced Colostrum

Additional Information

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 71950 7
DSLD Entry Date2021-09-24
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID258252
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
52
Avg Quality
8
Clinical Trial
4
Cochrane Review
2
Systematic Review
2
Meta Analysis
2
Guideline
1
Rct
B [Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
Guideline Zhonghua er ke za zhi = Chinese journal of pediatrics 2025 PubMed DOI
B Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
Guideline Kidney international 2025 PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Intravenous immunoglobulin for myasthenia gravis
Systematic Review The Cochrane database of systematic reviews 2003 PubMed
C Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
Rct Journal of medicinal food 2016 PubMed DOI
C Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
Meta Analysis Thyroid : official journal of the American Thyroid Association 2018 PubMed DOI
C Retinol-to-Fat Ratio and Retinol Concentration in Human Milk Show Similar Time Trends and Associations with Maternal Factors at the Population Level: A Systematic Review and Meta-Analysis
Meta Analysis Advances in nutrition (Bethesda, Md.) 2018 PubMed DOI
View all evidence for Colostrum →
Compare

Similar Products

View all Colostrum products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.